Graham D. Reeve, the Chief Operating Officer (COO) of U.S. Physical Therapy Inc. (NYSE:USPH), has sold a notable amount of company stock, according to a recent filing with the Securities and Exchange Commission. On August 21, 2024, Reeve sold 1,724 shares of common stock at an average price of $82.50 per share, totaling approximately $142,230.
The transaction has adjusted Reeve's direct holdings, as the shares sold were held indirectly through the Reeve Trust. Following the sale, the COO's direct ownership in the company stands at 7,038 shares. Additionally, the report included a footnote indicating that Reeve's remaining direct holdings include 14,676 shares of restricted stock granted under the company's Amended and Restated 2003 Stock Incentive Plan.
The filing provided a detailed footnote explaining that the reported price was a weighted average, and Reeve has committed to providing full information regarding the number of shares sold at each separate price upon request. The footnote also outlined the schedule for when the restrictions on the granted restricted stock would lapse, contingent upon Reeve's continued directorship at the company on specified future dates.
Investors and market watchers often scrutinize insider transactions such as these for insights into executive sentiment and potential future performance of the company's stock. U.S. Physical Therapy Inc., headquartered in Houston, Texas, is a national provider of outpatient physical therapy services and operates clinics across various states.
In other recent news, U.S. Physical Therapy, Inc. reported a record-breaking number of clinic visits for the second quarter of 2024, marking the highest in the company's history. Despite grappling with increased labor costs and potential cuts in Medicare reimbursement rates, the company demonstrated considerable volume growth and financial improvements. Adjusted EBITDA for Q2 2024 reached a noteworthy $22.1 million, while physical therapy revenues saw an 8.5% growth compared to the same period last year.
In addition, U.S. Physical Therapy emphasized its robust balance sheet, boasting $142.5 million in debt and a surplus of $90 million in cash designated for growth initiatives. The company is actively negotiating higher rates with commercial payers to counterbalance potential Medicare reimbursement rate cuts. It is also investing in recruitment and school partnerships to address labor shortages.
These recent developments suggest that U.S. Physical Therapy is strategically navigating its way through industry challenges, focusing on growth and efficiency. Full-year 2024 EBITDA is projected to be between $80 million to $85 million, indicating a promising outlook for the company.
InvestingPro Insights
As investors digest the news of COO Graham D. Reeve's recent stock sale in U.S. Physical Therapy Inc. (USPH), it's important to consider the company's financial health and market performance for a broader context. According to InvestingPro data, USPH has a market capitalization of $1.25 billion and is trading at a high earnings multiple with a P/E ratio of 78.54 as of Q2 2024, which adjusts to 51.14 when considering the last twelve months. This indicates that investors are paying a premium for USPH's earnings compared to the overall market. Despite this, the company has shown resilience with a revenue growth of 8.04% over the last twelve months leading up to Q2 2024, signaling a positive trend in its business operations.
One of the InvestingPro Tips highlights that USPH has raised its dividend for three consecutive years, and has maintained dividend payments for 14 consecutive years, which could be a sign of the company's commitment to returning value to shareholders. Additionally, the company's dividend yield stands at 2.12%, with a modest dividend growth rate of 2.33% over the last twelve months, as of Q2 2024. This could be of particular interest to income-focused investors. Moreover, analysts predict that USPH will be profitable this year, and the company has been profitable over the last twelve months.
While the sale by a high-level insider might raise questions, USPH's ability to cover its cash flows for interest payments and its moderate level of debt could provide some reassurance. For investors looking for further insights and analysis, there are additional InvestingPro Tips available for USPH at https://www.investing.com/pro/USPH, which could offer a more nuanced view of the company's financial position and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.